Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial. - Brun MK; Goll GL; Jørgensen KK; Sexton J; Gehin JE; Sandanger Ø; Olsen IC; Klaasen RA; Warren DJ; Mørk C; Kvien TK; Jahnsen J; et al. (Journal of internal medicine, 2022)